Foundation / Corporation
Grants to USA nonprofits, public schools and IHEs, agencies, hospitals, and Indian tribal governments for programs that benefit the medical and scientific community, public health, and patients. Requests must be consistent with a technological or therapeutic area in which Genentech or Roche is active.
The full list of funding priorities is as follows:
- Patient services
- Patient outreach
- Patient education
- Disease education
- Health screenings
- Scientific/medical meetings, conferences, seminars and symposia
Subject to certain conditions, Genentech may fund requests for general organizational support (i.e., for an unspecified purpose).
Genentech/Roche will consider funding requests in the following disease states:
- Age-Related Macular Degeneration (AMD)
- Allergic Asthma
- Basal Cell Carcinoma
- Bladder Cancer
- Breast Cancer
- Cervical Cancer
- Chronic Idiopathic Urticaria
- Chronic Lymphocytic Leukemia
- Colorectal Cancer
- Cystic Fibrosis
- Diabetic Macular Edema
- Diabetic Retinopathy
- Gastric Cancer
- Glioblastoma (GBM)
- Growth Hormone Deficiencies
- Idiopathic Pulmonary Fibrosis
- Juvenile Rheumatoid Arthritis
- Kidney Cancer
- Lung Cancer
- Macular Edema
- Multiple Sclerosis
- Ovarian Cancer
- Pancreatic Cancer
- Retinal Vein Occlusion
- Rheumatoid arthritis
GrantWatch ID#: 164283
Your organization must be recognized by the IRS as a tax exempt, public charity under sections 501(c)(3) and 501(c)(6) of the Internal Revenue Code and be located in the United States (or have W8-BEN status if not located in the United States); or be a US governmental organization (such as public schools, public colleges and universities, public hospitals and federally recognized Indian tribal governments).
Organizations that are not eligible for general organizational support include, but are not limited to: non-profit organizations and professional societies/associations that purchase Genentech/Roche products; and non-profit organizations that develop Medicare recognized compendia or nationally recognized treatment guidelines.
In order to be eligible for this type of funding, your organization must not be:
- A political or sectarian organization
- A group practice or private physician office
- Owned in whole or in part by a physician or a group of physicians
- A charitable foundation of a small group practice (less then 50 physicians)
In order to be eligible for this type of funding, the funding must not be used for:
- Advertising in medical journals
- Alumni drives
- Capital campaigns/building funds
- Continuing medical education
- Infrastructure costs request (e.g. salaries, equipment)
- Costs of holding a professional sports event or supporting professional athletes
- Religious purposes
- Developing clinical practice guidelines, e.g., statements that include recommendations intended to help practitioners make appropriate health care decisions for specific clinical conditions.
Genentech does not show preference in decision-making for funding requests with volunteering opportunities; however, if a volunteer opportunity is available, it must be open to the public.
Genentech cannot be the sole supporter of an event or program.
For scientific or medical meeting support, the funding must also follow the following criteria:
Funding is provided for the meeting as a whole and not earmarked for a specific section of the meeting. Funding must not be used for travel/lodging expenses for attendees (not including speakers/faculty) The meeting does not focus on specific brand names, and attendance is not limited to special committees or subgroups of the organization.
An organization with a written policy to discriminate based on race, religion, gender, gender expression and/or identify, age, national origin, disability, marital status, sexual orientation, military status, or any other protected status is ineligible for funding.
Due to the 2018 year-end close process, the Genentech Funding Request System will stop accepting healthcare-related charitable support requests at 5:00 PM PT, Wednesday, November 21 and will reopen for requests on Wednesday, January 2.
This temporary closure only affects healthcare-related charitable support.
It is important to note the Genentech Funding Request System cannot accept requests less than 60 days prior to the event/program start date. Therefore, if you plan to submit a charitable contribution request for an event or program occurring before March 3, 2019, please submit your request no later than November 21, to ensure consideration.
Pending requests with event/program dates beginning in mid-January 2019 or beyond will receive final decisions in the new year.
Genentech has a rolling review policy when evaluating funding requests for healthcare-related charitable support. This allows qualified requestors the opportunity to apply anytime during year.
Decisions are made on a case-by-case basis; you will usually hear back from Genentech prior to the project/program start date. Please refrain from submitting applications for which the project/program start date is more than 6 months out. Early submissions will not ensure an early decision.
Funding request process: https://www.gene.com/good/giving/corporate-giving/funding
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming